• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Therapy Area
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Delivery Mode
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global gene therapy market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global gene therapy market 2017 – 2021 ($ million)
o 4.2 Therapy area Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Therapy area Segment 2017 – 2021 ($ million)
o 4.3 Delivery mode Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Delivery mode Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Therapy Area
o 6.1 Market segments
o Exhibit 30: Chart on Therapy Area – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Therapy Area – Market share 2022-2027 (%)
o 6.2 Comparison by Therapy Area
o Exhibit 32: Chart on Comparison by Therapy Area
o Exhibit 33: Data Table on Comparison by Therapy Area
o 6.3 Oncology – Market size and forecast 2022-2027
o Exhibit 34: Chart on Oncology – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Oncology – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Oncology – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Oncology – Year-over-year growth 2022-2027 (%)
o 6.4 CNS – Market size and forecast 2022-2027
o Exhibit 38: Chart on CNS – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on CNS – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on CNS – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on CNS – Year-over-year growth 2022-2027 (%)
o 6.5 Ophthalmology – Market size and forecast 2022-2027
o Exhibit 42: Chart on Ophthalmology – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Ophthalmology – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Ophthalmology – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Ophthalmology – Year-over-year growth 2022-2027 (%)
o 6.6 Rare diseases – Market size and forecast 2022-2027
o Exhibit 46: Chart on Rare diseases – Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Rare diseases – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Rare diseases – Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Rare diseases – Year-over-year growth 2022-2027 (%)
o 6.7 Others – Market size and forecast 2022-2027
o Exhibit 50: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Therapy Area
o Exhibit 54: Market opportunity by Therapy Area ($ million)
• 7 Market Segmentation by Delivery Mode
o 7.1 Market segments
o Exhibit 55: Chart on Delivery Mode – Market share 2022-2027 (%)
o Exhibit 56: Data Table on Delivery Mode – Market share 2022-2027 (%)
o 7.2 Comparison by Delivery Mode
o Exhibit 57: Chart on Comparison by Delivery Mode
o Exhibit 58: Data Table on Comparison by Delivery Mode
o 7.3 In vivo – Market size and forecast 2022-2027
o Exhibit 59: Chart on In vivo – Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on In vivo – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on In vivo – Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on In vivo – Year-over-year growth 2022-2027 (%)
o 7.4 Ex vivo – Market size and forecast 2022-2027
o Exhibit 63: Chart on Ex vivo – Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on Ex vivo – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on Ex vivo – Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on Ex vivo – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Delivery Mode
o Exhibit 67: Market opportunity by Delivery Mode ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 69: Chart on Market share by geography 2022-2027 (%)
o Exhibit 70: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 71: Chart on Geographic comparison
o Exhibit 72: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 73: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 77: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 81: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 85: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 89: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 UK – Market size and forecast 2022-2027
o Exhibit 93: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.9 China – Market size and forecast 2022-2027
o Exhibit 97: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.10 Canada – Market size and forecast 2022-2027
o Exhibit 101: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 105: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 106: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 107: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 108: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 109: Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 110: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 112: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 113: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 114: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 115: Matrix on vendor position and classification
o 12.3 Abeona Therapeutics Inc.
o Exhibit 116: Abeona Therapeutics Inc. – Overview
o Exhibit 117: Abeona Therapeutics Inc. – Product / Service
o Exhibit 118: Abeona Therapeutics Inc. – Key offerings
o 12.4 Amgen Inc.
o Exhibit 119: Amgen Inc. – Overview
o Exhibit 120: Amgen Inc. – Product / Service
o Exhibit 121: Amgen Inc. – Key offerings
o 12.5 Astellas Pharma Inc.
o Exhibit 122: Astellas Pharma Inc. – Overview
o Exhibit 123: Astellas Pharma Inc. – Product / Service
o Exhibit 124: Astellas Pharma Inc. – Key offerings
o 12.6 Biogen Inc.
o Exhibit 125: Biogen Inc. – Overview
o Exhibit 126: Biogen Inc. – Product / Service
o Exhibit 127: Biogen Inc. – Key offerings
o 12.7 bluebird bio Inc.
o Exhibit 128: bluebird bio Inc. – Overview
o Exhibit 129: bluebird bio Inc. – Product / Service
o Exhibit 130: bluebird bio Inc. – Key offerings
o 12.8 ElevateBio
o Exhibit 131: ElevateBio – Overview
o Exhibit 132: ElevateBio – Product / Service
o Exhibit 133: ElevateBio – Key offerings
o 12.9 F. Hoffmann La Roche Ltd.
o Exhibit 134: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 135: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 136: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 137: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 138: F. Hoffmann La Roche Ltd. – Segment focus
o 12.10 Generation Bio Co.
o Exhibit 139: Generation Bio Co. – Overview
o Exhibit 140: Generation Bio Co. – Product / Service
o Exhibit 141: Generation Bio Co. – Key offerings
o 12.11 Gilead Sciences Inc.
o Exhibit 142: Gilead Sciences Inc. – Overview
o Exhibit 143: Gilead Sciences Inc. – Product / Service
o Exhibit 144: Gilead Sciences Inc. – Key news
o Exhibit 145: Gilead Sciences Inc. – Key offerings
o 12.12 Novartis AG
o Exhibit 146: Novartis AG – Overview
o Exhibit 147: Novartis AG – Business segments
o Exhibit 148: Novartis AG – Key offerings
o Exhibit 149: Novartis AG – Segment focus
o 12.13 Orchard Therapeutics Plc
o Exhibit 150: Orchard Therapeutics Plc – Overview
o Exhibit 151: Orchard Therapeutics Plc – Product / Service
o Exhibit 152: Orchard Therapeutics Plc – Key offerings
o 12.14 Poseida Therapeutics Inc.
o Exhibit 153: Poseida Therapeutics Inc. – Overview
o Exhibit 154: Poseida Therapeutics Inc. – Product / Service
o Exhibit 155: Poseida Therapeutics Inc. – Key offerings
o 12.15 Sibiono GeneTech Co. Ltd.
o Exhibit 156: Sibiono GeneTech Co. Ltd. – Overview
o Exhibit 157: Sibiono GeneTech Co. Ltd. – Product / Service
o Exhibit 158: Sibiono GeneTech Co. Ltd. – Key offerings
o 12.16 uniQure NV
o Exhibit 159: uniQure NV – Overview
o Exhibit 160: uniQure NV – Product / Service
o Exhibit 161: uniQure NV – Key offerings
o 12.17 Voyager Therapeutics Inc.
o Exhibit 162: Voyager Therapeutics Inc. – Overview
o Exhibit 163: Voyager Therapeutics Inc. – Product / Service
o Exhibit 164: Voyager Therapeutics Inc. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 165: Inclusions checklist
o Exhibit 166: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 167: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 168: Research methodology
o Exhibit 169: Validation techniques employed for market sizing
o Exhibit 170: Information sources
o 13.5 List of abbreviations
o Exhibit 171: List of abbreviations
Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Therapy Area
Exhibits6: Executive Summary – Chart on Market Segmentation by Delivery Mode
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global gene therapy market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Therapy area Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Delivery mode Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Therapy Area – Market share 2022-2027 (%)
Exhibits31: Data Table on Therapy Area – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Therapy Area
Exhibits33: Data Table on Comparison by Therapy Area
Exhibits34: Chart on Oncology – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Oncology – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Oncology – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Oncology – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on CNS – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on CNS – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on CNS – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on CNS – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Ophthalmology – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Ophthalmology – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Ophthalmology – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Ophthalmology – Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Rare diseases – Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Rare diseases – Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Rare diseases – Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Rare diseases – Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits52: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Therapy Area ($ million)
Exhibits55: Chart on Delivery Mode – Market share 2022-2027 (%)
Exhibits56: Data Table on Delivery Mode – Market share 2022-2027 (%)
Exhibits57: Chart on Comparison by Delivery Mode
Exhibits58: Data Table on Comparison by Delivery Mode
Exhibits59: Chart on In vivo – Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on In vivo – Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on In vivo – Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on In vivo – Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on Ex vivo – Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on Ex vivo – Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on Ex vivo – Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on Ex vivo – Year-over-year growth 2022-2027 (%)
Exhibits67: Market opportunity by Delivery Mode ($ million)
Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits69: Chart on Market share by geography 2022-2027 (%)
Exhibits70: Data Table on Market share by geography 2022-2027 (%)
Exhibits71: Chart on Geographic comparison
Exhibits72: Data Table on Geographic comparison
Exhibits73: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits109: Market opportunity by geography ($ million)
Exhibits110: Impact of drivers and challenges in 2022 and 2027
Exhibits111: Overview on Criticality of inputs and Factors of differentiation
Exhibits112: Overview on factors of disruption
Exhibits113: Impact of key risks on business
Exhibits114: Vendors covered
Exhibits115: Matrix on vendor position and classification
Exhibits116: Abeona Therapeutics Inc. – Overview
Exhibits117: Abeona Therapeutics Inc. – Product / Service
Exhibits118: Abeona Therapeutics Inc. – Key offerings
Exhibits119: Amgen Inc. – Overview
Exhibits120: Amgen Inc. – Product / Service
Exhibits121: Amgen Inc. – Key offerings
Exhibits122: Astellas Pharma Inc. – Overview
Exhibits123: Astellas Pharma Inc. – Product / Service
Exhibits124: Astellas Pharma Inc. – Key offerings
Exhibits125: Biogen Inc. – Overview
Exhibits126: Biogen Inc. – Product / Service
Exhibits127: Biogen Inc. – Key offerings
Exhibits128: bluebird bio Inc. – Overview
Exhibits129: bluebird bio Inc. – Product / Service
Exhibits130: bluebird bio Inc. – Key offerings
Exhibits131: ElevateBio – Overview
Exhibits132: ElevateBio – Product / Service
Exhibits133: ElevateBio – Key offerings
Exhibits134: F. Hoffmann La Roche Ltd. – Overview
Exhibits135: F. Hoffmann La Roche Ltd. – Business segments
Exhibits136: F. Hoffmann La Roche Ltd. – Key news
Exhibits137: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits138: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits139: Generation Bio Co. – Overview
Exhibits140: Generation Bio Co. – Product / Service
Exhibits141: Generation Bio Co. – Key offerings
Exhibits142: Gilead Sciences Inc. – Overview
Exhibits143: Gilead Sciences Inc. – Product / Service
Exhibits144: Gilead Sciences Inc. – Key news
Exhibits145: Gilead Sciences Inc. – Key offerings
Exhibits146: Novartis AG – Overview
Exhibits147: Novartis AG – Business segments
Exhibits148: Novartis AG – Key offerings
Exhibits149: Novartis AG – Segment focus
Exhibits150: Orchard Therapeutics Plc – Overview
Exhibits151: Orchard Therapeutics Plc – Product / Service
Exhibits152: Orchard Therapeutics Plc – Key offerings
Exhibits153: Poseida Therapeutics Inc. – Overview
Exhibits154: Poseida Therapeutics Inc. – Product / Service
Exhibits155: Poseida Therapeutics Inc. – Key offerings
Exhibits156: Sibiono GeneTech Co. Ltd. – Overview
Exhibits157: Sibiono GeneTech Co. Ltd. – Product / Service
Exhibits158: Sibiono GeneTech Co. Ltd. – Key offerings
Exhibits159: uniQure NV – Overview
Exhibits160: uniQure NV – Product / Service
Exhibits161: uniQure NV – Key offerings
Exhibits162: Voyager Therapeutics Inc. – Overview
Exhibits163: Voyager Therapeutics Inc. – Product / Service
Exhibits164: Voyager Therapeutics Inc. – Key offerings
Exhibits165: Inclusions checklist
Exhibits166: Exclusions checklist
Exhibits167: Currency conversion rates for US$
Exhibits168: Research methodology
Exhibits169: Validation techniques employed for market sizing
Exhibits170: Information sources
Exhibits171: List of abbreviations
